Price Alert

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

14.26

-0.31 (-2.13%)

At close: Aug 19, 2025, 10:24 AM

MBX Biosciences Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Revenue	n/a	n/a	222K	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	100K	77K	n/a	100K	63K	48K	n/a	100K	39K
Gross Profit	-100K	-77K	111K	-100K	-63K	-48K	n/a	-100K	-39K
Operating Income	-21.8M	-26.53M	-18.61M	-19.61M	-16.66M	-13.31M	-9.99M	-10.95M	-8.01M
Interest Income	2.39M	2.65M	3.02M	1.47M	801K	977K	1.15M	783K	399K
Pretax Income	-19.41M	-23.88M	-15.59M	-18.14M	-15.86M	-12.34M	-8.84M	-10.16M	-7.61M
Net Income	-19.41M	-23.88M	-15.59M	-18.14M	-15.86M	-12.34M	-8.84M	-10.16M	-7.61M
Selling & General & Admin	4.08M	4.12M	3.39M	2.87M	2.2M	2.22M	2.26M	1.87M	1.49M
Research & Development	17.72M	22.41M	15.22M	16.75M	14.4M	11.05M	7.73M	9.07M	6.47M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	21.8M	26.53M	18.61M	19.61M	16.59M	13.27M	9.99M	10.95M	7.97M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	21.8M	26.53M	18.61M	19.61M	-16.66M	-13.31M	9.99M	10.95M	-8.01M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	33.45M	33.41M	33.39M	33.39M	33.38M	33.38M	31.85M	31.85M	33.38M
Shares Outstanding (Diluted)	33.45M	33.41M	33.39M	33.39M	33.38M	33.38M	31.85M	31.85M	33.38M
EPS (Basic)	-0.58	-0.71	-0.47	-0.54	-0.48	-0.37	-0.28	-0.32	-0.23
EPS (Diluted)	-0.58	-0.71	-0.47	-0.54	-0.48	-0.37	-0.28	-0.32	-0.23
EBITDA	-21.8M	-26.53M	-20.33M	-19.54M	-15.79M	-12.29M	-7.2M	-10.9M	-7.57M
EBIT	-19.41M	-23.88M	-20.39M	-19.61M	-15.86M	-12.34M	-7.24M	-10.95M	-7.61M
Depreciation & Amortization	n/a	77K	58K	75K	63K	48K	41K	40K	39K